Holdings
Lion Point Capital, LP
As of Sep 30, 2026, Lion Point Capital, LP reported 30 positions worth US$14.6M. Largest: Cue Biopharma, Inc., Praxis Precision Medicines, Inc. and Fennec Pharmaceuticals Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cue Biopharma, Inc. | 52,928 | US$1.37M | no change | Sep 30, 2026 |
| Praxis Precision Medicines, Inc. | 4,450 | US$1.3M | no change | Sep 30, 2026 |
| Fennec Pharmaceuticals Inc. | 112K | US$1.2M | no change | Sep 30, 2026 |
| COMPASS Pathways Plc | 80,000 | US$995K | new | Sep 30, 2026 |
| Geron Corporation | 578K | US$711K | no change | Sep 30, 2026 |
| Milestone Pharmaceuticals Inc. | 820K | US$710K | no change | Sep 30, 2026 |
| Biohaven Ltd. | 51,700 | US$690K | no change | Sep 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 36,000 | US$677K | no change | Sep 30, 2026 |
| Benitec Biopharma Inc. | 62,000 | US$620K | no change | Sep 30, 2026 |
| Disc Medicine, Inc. | 8,100 | US$530K | no change | Sep 30, 2026 |